Sacramento, Calif., Sept. 28, 2012 /PRNewswire/ -- Critical care physician Muhammad Afzal, M.D. smiled as he recalled saving a patient's life -- from a room miles away from the bedside. The lucky man was just one of hundreds of patients Dr. Afzal...
RIDGEFIELD, Conn., Sept. 28, 2012 /PRNewswire/ -- Boehringer Ingelheim today announced new patient-reported health-related outcomes for its investigational oncology compound afatinib,* including lung cancer-related symptoms and quality of life (QoL). These data are secondary endpoints of LUX-Lung 3, a Phase III...
SOUTH PLAINFIELD, N.J., Sept. 28, 2012 /PRNewswire/ -- PTC Therapeutics, Inc. (PTC) today announced the appointment of Jerome B. Zeldis, M.D., Ph.D., to the company's Board of Directors. Dr. Zeldis is the Chief Executive Officer of Celgene Global Health and the Chief...
SCHAUMBURG, Ill., Sept. 28, 2012 /PRNewswire/ -- Wellness Center USA, Inc. (OTCQB: WCUI), a Schaumburg, IL based healthcare and nutraceutical company, today announced the creation of a group of neuropsychologists, physiologists and medical device engineers to design and develop a set...
NEW YORK, Sept. 28, 2012 /PRNewswire/ -- There are two common dilemmas in the treatment of cancer today: the first is that many therapies, including chemotherapies and radiation can debilitate healthy cells, to the point of killing the person before...
BOISE, Idaho, Sept. 28, 2012 /PRNewswire-iReach/ -- Stat PADS, the leading independent provider of Physician Oversight & Medical Direction nationwide, today announced it has awarded Cintas Corporation with its Heart Award, an annual award that recognizes businesses and organizations for their...
REDWOOD CITY, Calif., and VIENNA, Sept. 28, 2012 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced the presentation of data that support expanded use of the Oncotype DX® tests in optimizing treatment decisions for breast and colon cancer patients at...
NEW DELHI, September 28, 2012 /PRNewswire/ -- Having successfully conducted over 130,000 cardiac surgeries - among the highest by any centre globally - coupled with a success rate of 99.6%, Apollo Hospitals Group took a step forward in achieving its...
SALT LAKE CITY, Sept. 28, 2012 /PRNewswire/ -- Dynatronics Corporation (NASDAQ: DYNT) today announced results for its fiscal fourth quarter and year ended June 30, 2012. Net income for the quarter ended June 30, 2012, increased to $115,954 ($.01 per common...
MONMOUTH JUNCTION, N.J., Sept. 28, 2012 /PRNewswire/ -- Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company focused on developing novel inhalation therapeutics for patients suffering from serious orphan lung diseases, today announced that it has priced a direct public offering of approximately...
